Medical Devices
-
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
By Elise Reuter • June 11, 2026 -
Danaher closes $9.9B Masimo buyout
CEO Rainer Blair said Danaher has the money and “leadership bandwidth” to strike further deals across any of its three business areas.
By Nick Paul Taylor • June 11, 2026 -
Explore the Trendline➔
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
GT Medical raises $100M for brain tumor tech after clinical trial success
Adoption of the GammaTile radiotherapy implant is growing, the company said, and the new funding round validates its potential to be a standard of care treatment.
By Susan Kelly • June 10, 2026 -
Bausch + Lomb to lay off employees in Missouri
The company plans to eliminate 119 positions by mid-December as part of a phased transfer of some production from the manufacturing site.
By Nick Paul Taylor • June 10, 2026 -
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
By Elise Reuter • June 9, 2026 -
Medtronic set for Stealth AXiS expansion in Europe
With the CE mark for ear, nose and throat procedures, the advanced surgical navigation platform will be available to more surgeons across the region.
By Susan Kelly • June 9, 2026 -
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
By Elise Reuter • June 9, 2026 -
Medtronic gets FDA nod for updated pulse oximetry system
The changes support accuracy across diverse patient populations, skin tones and clinical care settings.
By Nick Paul Taylor • June 9, 2026 -
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
By Elise Reuter • June 8, 2026 -
Boston Scientific to build Indiana distribution center
The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s medical devices.
By Nick Paul Taylor • June 8, 2026 -
J&J, Medtronic back CereVasc’s $85M funding round
CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.
By Nick Paul Taylor • June 5, 2026 -
Q&A
Olympus’ Keith Boettiger on robotic GI surgery push
Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.
By Susan Kelly • June 5, 2026 -
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
By Elise Reuter • June 5, 2026 -
Deep Dive
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
By Elise Reuter • June 4, 2026 -
Medtronic seeks clearance for Hugo surgical robot in more indications
Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.
By Nick Paul Taylor • June 4, 2026 -
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
By Susan Kelly • June 3, 2026 -
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
By Elise Reuter • June 3, 2026 -
Resmed completes $340M Noctrix takeover
The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.
By Nick Paul Taylor • June 2, 2026 -
Intuitive elevates Taylor Patton to chief commercial and marketing officer
Patton’s promotion comes as competition in robotic surgery intensifies, and Intuitive looks to expand its global commercial operations to meet anticipated growth.
By Susan Kelly • June 1, 2026 -
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
By Nick Paul Taylor • June 1, 2026 -
California attorney general sues over 23andMe data breach
The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.
By Elise Reuter • May 29, 2026 -
J&J recalls Impella heart pumps after patient dies
Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.
By Nick Paul Taylor • May 29, 2026 -
Ōura to add blood pressure feature following FDA policy change
The new wellness tool would alert users to signs of increasing blood pressure. Ōura is studying a separate feature to flag hypertension that would go through the Food and Drug Administration.
By Elise Reuter • May 28, 2026 -
Siemens Healthineers, AiM team up; Procept completes study enrollment
Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.
By Susan Kelly • May 28, 2026 -
Abbott receives CE mark for dual glucose-ketone sensor
Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.
By Elise Reuter • May 27, 2026